Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 01)
Topiramate
Product Images NDC 70934-133
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 02)
The text appears to be a graph showing cumulative rates over time. The x-axis seems to be in units of 50 (ranging from 100 to 450) and the y-axis appears to show the cumulative rates ranging from 0.0 to 0.3. The text on the graph reads "p=0.0002." Without additional context, it is difficult to determine what the graph is specifically measuring or representing.*
Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (6491d395 Ef69 4db7 Abe1 87f061db14d8 03)
70934 133 30 Master Bottle Label Approval Rev B 10 19
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
